Institut Curie Installs World’s First Biograph Trinion.X PET-CT Scanner
The Institut Curie has installed the world’s first Siemens Healthineers Biograph Trinion.X PET-CT scanner at its Saint-Cloud facility. This advanced imaging technology allows for more precise tumor visualization, faster patient exams, and reduced radioactive tracer doses, according to Dr. Romain-David Seban, who leads the site’s Nuclear Medicine department.
PET-CT imaging combines positron emission tomography and computed tomography to track metabolic activity within the body. The integration of this specific medium-field scanner is intended to improve both clinical diagnostics and ongoing cancer treatment monitoring.
Did You Know?
The installation of the Biograph Trinion.X was a global first for the manufacturer Siemens Healthineers, requiring significant facility modifications and a phased startup period to ensure staff familiarity and patient safety.
How the new technology improves patient care
The Biograph Trinion.X features an extended axial field of view, which enables the system to capture images of larger body areas in a single scan. Dr. Seban states that this capability reduces the time patients spend in the machine, increasing overall comfort and improving service efficiency. Furthermore, the scanner’s high-sensitivity detectors allow for clearer visualization of small lesions. These technical upgrades mean clinicians may be able to maintain high image quality while lowering the amount of radioactive tracer injected into patients.
Integration and research potential
The machine serves as more than a diagnostic tool; it is expected to support advanced medical research. Dr. Seban, who is affiliated with the Imaging, Radiotherapy, and Systems Medicine unit led by Dr. Irène Buvat, notes that the new scanner provides data that could lead to more personalized patient care. By better utilizing information captured in medical images, researchers aim to refine how they monitor disease progression and treatment efficacy.
Expert Insight:
The shift toward high-sensitivity imaging with lower tracer doses represents a significant trade-off in nuclear medicine. By maximizing the data extracted from each scan, institutions like the Institut Curie may reduce the physiological burden on patients while simultaneously increasing the granular detail available for longitudinal cancer tracking.
What happens next for the Saint-Cloud facility
Following the initial phased startup, the staff at Saint-Cloud is expected to fully integrate the scanner into the routine clinical workflow. Future developments likely include the expansion of research projects under the direction of Dr. Buvat’s team. As the staff gains proficiency, the facility may begin to leverage the machine’s full capability to tailor treatment plans based on more precise metabolic data.
Frequently Asked Questions
What is the primary benefit of the new Biograph Trinion.X scanner?
The scanner features a larger axial field of view, which allows for faster exams and higher-quality images of small lesions while potentially reducing the amount of radioactive tracer needed for patients.
Where is this new equipment located?
The technology is currently installed and operational at the Institut Curie’s site in Saint-Cloud.
Why is this installation considered a “first”?
According to the Institut Curie, this is the first machine of the Biograph Trinion.X model to be installed anywhere in the world by the manufacturer, Siemens Healthineers.
How do you think faster diagnostic imaging technology might change the way patients experience cancer treatment?